Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/5706
Title: | Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD | Authors: | Siriratnam, P. Huda, S. Van, Der, Walt, A. Sanfilippo, P.G. Sharmin, S. Foong, Y.C. Yeh, W.Z. |
Keywords: | Adult Aquaporin 4 Autoantibodies Cohort Studies Disability Evaluation Disease Progression Female Humans Immunoglobulin G Male Middle Aged Neuromyelitis Optica Prevalence Recurrence Retrospective Studies AQP4 protein, human aquaporin 4 autoantibody immunoglobulin G adult blood clinical trial cohort analysis disability assessment disease exacerbation epidemiology female human immunology male middle aged multicenter study myelooptic neuropathy prevalence recurrent disease retrospective study |
Abstract: | OBJECTIVES: In aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-IgG NMOSD), disability accrual is mostly attributed to relapses. This study aimed to assess the prevalence of progression independent of relapse activity (PIRA) and relapse-associated worsening (RAW) in AQP4-IgG NMOSD. METHODS: This was a retrospective cohort study of patients with AQP4-IgG NMOSD enrolled in the MSBase international data registry. Patients required a minimum of 3 recorded Expanded Disability Status Scale (EDSS) scores: baseline, event, and a 6-month confirmation score. Presence and absence of relapses between the baseline and event EDSS scores determined RAW and PIRA, respectively. Descriptive statistics were used to present the results. RESULTS: A total of 181 patients followed for a median of 4.5 years (Q1 1.7, Q3 7.8) were included. Most patients were female (88.4%), and the median age at disease onset was 38.1 years. Overall, 4 patients (2.2%) developed 5 incidences of PIRA and 13 patients developed RAW (7.2%). DISCUSSION: This multicenter study highlights that PIRA is very rare in AQP4-IgG NMOSD. Limitations of this study include the sole focus of overall EDSS to measure disability, lack of requirement for a second EDSS score to confirm baseline EDSS, and the absence of magnetic resonance imaging information for all patients. | URI: | https://doi.org/10.1212/WNL.0000000000209940 https://hdl.handle.net/20.500.14365/5706 |
ISSN: | 1526-632X |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection |
Show full item record
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.